In the February 2010 issue of Nature Reviews Neurology, an entry in Table 1 was incorrect. In the third entry for bapineuzumab, the antibody column should have read: anti-Aβ amino-terminal MAb.
Additional information
The online version of the original article can be found at 10.1038/nrneurol.2009.219
Rights and permissions
About this article
Cite this article
Lemere, C., Masliah, E. Correction: Can Alzheimer disease be prevented by amyloid-β immunotherapy?. Nat Rev Neurol 6, 183 (2010). https://doi.org/10.1038/nrneurol.2010.47
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2010.47
This article is cited by
-
Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease
Alzheimer's Research & Therapy (2015)
